MILLER JOSEPH M (Chief Financial Officer) received a stock award from AURINIA PHARMACEUTICALS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/5/2026ACC: 0001600620-26-000003
Officer· Chief Financial Officer
Since Jan 2021
+8.88K
Net shares
Net buyer
$640.6K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
49.04K acquired · 40.16K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+49.04K
Price / share
—
Trade value
—
% of position
8.5%
1/2/2026
577.36K→626.40K
Common Stock
Direct
Shares
−40.16K
Price / share
$15.95
Trade value
$640.57K
% of position
6.4%
1/2/2026
629.29K→589.13K
Total
Net shares
+8.88K
Net value
-$640.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | A · Award | +49.04K | — | — | 8.5% | 577.36K | 626.40K |
| Common Stock Direct | 1/2/2026 | F · Tax Withholding | −40.16K | $15.95 | $640.57K | 6.4% | 629.29K | 589.13K |
| Total | +8.88K | -$640.57K | ||||||
Derivative Transactions0
No derivative transactions reported